Beyond Recycling Antibodies: Crovalimab's Molecular Design Enables Four-Weekly Subcutaneous Injections for PNH Treatment.

Sampei Z, Haraya K, Gan SW, Muraoka M, Hayasaka A, Fukuzawa T, Shida-Kawazoe M, Tsuboi Y, Gotoh A, Obara N, Ueda Y

DOI: 10.3390/ijms252111679
Published: 2024 Oct 30
Container: International journal of molecular sciences
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/ijms252111679,
  title = {Beyond Recycling Antibodies: Crovalimab's Molecular Design Enables Four-Weekly Subcutaneous Injections for PNH Treatment.},
  author = {Sampei Z and Haraya K and Gan SW and Muraoka M and Hayasaka A and Fukuzawa T and Shida-Kawazoe M and Tsuboi Y and Gotoh A and Obara N and Ueda Y},
  year = {2024},
  journal = {International journal of molecular sciences},
  doi = {10.3390/ijms252111679},
  url = {https://doi.org/10.3390/ijms252111679}
}

RIS

TY  - JOUR
TI  - Beyond Recycling Antibodies: Crovalimab's Molecular Design Enables Four-Weekly Subcutaneous Injections for PNH Treatment.
AU  - Sampei Z
AU  - Haraya K
AU  - Gan SW
AU  - Muraoka M
AU  - Hayasaka A
AU  - Fukuzawa T
AU  - Shida-Kawazoe M
AU  - Tsuboi Y
AU  - Gotoh A
AU  - Obara N
AU  - Ueda Y
PY  - 2024
JO  - International journal of molecular sciences
DO  - 10.3390/ijms252111679
UR  - https://doi.org/10.3390/ijms252111679
ER  -

APA

Z, S., K, H., SW, G., M, M., A, H., T, F., M, S., Y, T., A, G., N, O., & Y, U. (2024). Beyond Recycling Antibodies: Crovalimab's Molecular Design Enables Four-Weekly Subcutaneous Injections for PNH Treatment.. International journal of molecular sciences. https://doi.org/10.3390/ijms252111679

Source records

pubmed · retrieved 2026-09-27T15:53:10.523Z